InflaRx NV (NAS:IFRX) Stock News, Headlines & Updates
InflaRx NV Stock News from GuruFocus
- 1
Jun 24, 2024
InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
Marketwired • 8:00am
Jun 05, 2024
InflaRx Hosts R&D Event Highlighting the Promise of INF904
Marketwired • 11:00am
May 21, 2024
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
Marketwired • 2:00pm
Apr 30, 2024
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
Marketwired • 7:00am
Apr 24, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news